• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2200275 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2022-12-13 Lilly Suzhou Pharmaceutical Co Ltd view
CYSB2500095 赖脯胰岛素注射液 insulin lispro Injection Biological Products Supplementary Application 2025-05-09 Lilly Suzhou Pharmaceutical Co Ltd view
CXSL2500272 注射用LY4101174 LY4101174 Lyophilized Biological Products(1) New Drug Application 2025-04-08 Lilly Suzhou Pharmaceutical Co Ltd view
CYSB2101210 人胰岛素注射液 human insulin Injection Biological Products Supplementary Application 2021-10-09 Lilly Suzhou Pharmaceutical Co Ltd view
CXSL2500049 注射用LY4052031 LY-4052031 Biological Products(1) New Drug Application 2025-01-16 Lilly Suzhou Pharmaceutical Co Ltd view
CYSB2101244 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2021-10-28 Lilly Suzhou Pharmaceutical Co Ltd view
CXSL2400415 LY3540378注射液 Injection Biological Products(1) New Drug Application 2024-06-27 Lilly Suzhou Pharmaceutical Co Ltd view
CYSB2200013 赖脯胰岛素注射液 insulin lispro Injection Biological Products Supplementary Application 2022-01-13 Lilly Suzhou Pharmaceutical Co Ltd view
JYSB2000275 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2020-06-18 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Eli Lilly Italia SpA Filed 2020-06-22 view
JYHB2000722 盐酸托莫西汀口服溶液 atomoxetine hydrochloride Oral solution Chemical Drugs Supplementary Application 2020-06-06 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company Ltd;Patheon France Filed 2020-06-16 view
JXHB2100003 LOXO-305 pirtobrutinib Active ingredient Chemical Drugs(1) Supplementary Application 2021-01-08 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company;Lilly Del Caribe Inc In Review 2021-01-07 view
JYSB2000465 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2020-09-17 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Lilly France;Eli Lilly Nederland BV Filed 2020-09-29 view
JYHB2001329 盐酸度洛西汀肠溶胶囊 duloxetine hydrochloride Capsule Chemical Drugs Supplementary Application 2020-08-10 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company;Lilly Del Caribe Inc Filed 2020-08-21 view
JYSB2000238 Mirikizumab注射液 mirikizumab Injection Biological Products Supplementary Application 2020-06-19 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2020-06-18 view
JYHB2000735 奥氮平口崩片 olanzapine Tablet Chemical Drugs Supplementary Application 2020-06-06 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Catalent Uk Swindon Zydis Ltd;Eli Lilly Nederland BV Filed 2020-06-19 view
JXHL2100092 LOXO-305 pirtobrutinib Active ingredient Chemical Drugs(1) Import Drug Application 2021-03-20 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc In Review 2021-03-19 view
JYHB2002215 奥氮平口崩片 olanzapine Tablet Chemical Drugs Supplementary Application 2020-11-04 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Catalent Uk Swindon Zydis Ltd;Eli Lilly Nederland BV Certificate Issued 2021-03-01 view
JXHB2000016 Tirzepatide注射液 tirzepatide Injection Chemical Drugs(1) Supplementary Application 2020-08-25 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2020-08-24 view
JYHB2001062 奥氮平口崩片 olanzapine Tablet Chemical Drugs Supplementary Application 2020-06-29 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Catalent Uk Swindon Zydis Ltd;Eli Lilly Nederland BV Filed 2020-06-30 view
JYHB2000740 盐酸托莫西汀胶囊 atomoxetine hydrochloride Capsule Chemical Drugs Supplementary Application 2020-06-10 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Lilly SA;Lilly Del Caribe Inc Filed 2020-06-17 view